Product
SCT800
1 clinical trial
1 indication
Indication
Hemophilia A with inhibitorClinical trial
The Outcome Comparison of Immune Tolerance Induction Therapy Using SCT800 Combined With Daratumumab or SCT800 Alone in Hemophilia A Adolescents and Adults With High Titer Inhibitor: a Non-randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2026-12-01